Clinical Application Value of Circulating Cell-free DNA in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide and a leading cause of cancer-related deaths. Due to late diagnosis, early intrahepatic metastasis and nonresponse to systemic treatments, surgical resection and/or biopsy specimens remain the gold standard for disease stagin...
Main Authors: | Yuyuan Zhang, Zaoqu Liu, Kun Ji, Xin Li, Caihong Wang, Zhigang Ren, Yang Liu, Xinju Chen, Xinwei Han, Lingfang Meng, Lifeng Li, Zhen Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Molecular Biosciences |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2021.736330/full |
Similar Items
-
Comprehensive Molecular Analyses of a Six-Gene Signature for Predicting Late Recurrence of Hepatocellular Carcinoma
by: Yuyuan Zhang, et al.
Published: (2021-09-01) -
International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA
by: Cleo Keppens, et al.
Published: (2018-08-01) -
MET alterations detected in blood-derived circulating tumor DNA correlate with bone metastases and poor prognosis
by: Sadakatsu Ikeda, et al.
Published: (2018-06-01) -
The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review
by: Ian A. Cree, et al.
Published: (2017-10-01) -
Mutated circulating tumor DNA as a liquid biopsy in lung cancer detection and treatment
by: Martyna Filipska, et al.
Published: (2021-06-01)